Ilomedin (iloprost) 20 micrograms/mL solution for infusion, 1 mL ampoules *5 (Bayer Pharma) Targeted cancer therapy. Drug delivery from Europe within 4-5 days, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Progressive obliterative thromboangitis (Buerger's disease) in severely impaired perfusion is always indicated before revascularization.

Over the first 2-3 days, determine individual tolerance to the drug - treatment with dose 0.5 ng/kg/xv increase 30 hvilin. After this, increase the oral dose by 0.5 ng/kg/min approximately through the skin 30 days until a maximum dose of 2.0 ng/kg/min is reached. The exact fluidity of the infusion is determined, based on body weight, in the range of 0.5 to 2.0 ng/kg/xv (lower than the table of fluidity of infusion with a variable infusion pump or automatic syringe).